1 潘德田, 田钗, 陈兰英.关于心肌肥厚发生机制的探讨[J]. 生理科学进展, 1999;30: 115. 2 Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cell [J]. Nature, 1988;332: 411-415. 3 Hong HJ, Chan P, Liu JC, et al. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells[J]. Cardiovasc Res, 2004;61:159-168. 4 Kaddoura S, Firth JD, Boheler KR, et al. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo: Acute effects of bosentan, an orally active, mixed endothelin ET(A) and ET(B) receptor antagonist[J], Circulation, 1996;93:2068-2079. 5 Kawaguchi H, Sawa H, Yasuda H.Effect of endothelin on angiotensin converting enzyme activity in cultured pulmonary artery endothelial cells[J]. J Hypertens, 1991; 9:171. 6 Jesmin S, Sakuma I, Togashi H, et al. Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP[J]. J Cardiovasc Pharmacol, 2004;44: S59-S63. 7 Massart PE, Hodeige DG, VanMechelen H, et al. Angiotensin Ⅱ and endothelin-1 receptor antagonists have cumulative hypotensive effects in canine page hypertension[J]. J Hypertens, 1998;16:835-841. 8 Bohlender J, Gerbaulet S, Kramer J, et al. Synergistic effects of AT1 and ETA receptor blockade in a transgenic, angiotensin Ⅱ-dependent, rat model[J]. Hypertension, 2000;35:992-997. 9 魏臻, 徐进宜, 吴晓明, 等.新型血管紧张素Ⅱ 受体和内皮素受体双重拮抗剂研究进展[J]. 药学进展, 2006;30: 193-199. |